JoanneLauretteBillingsMD
Pulmonology • Minneapolis, MNCritical Care Medicine, Pleural Disease
Associate Professor, Medicine, University of Minnesota Medical School
Dr. Billings is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
909 Fulton Ave. SE
M Health Fairview CSC
Minneapolis, MN 55455Phone+1 612-273-8383
Education & Training
University of MinnesotaFellowship, Pulmonary Disease and Critical Care Medicine, 1996 - 2000- University of MinnesotaResidency, Internal Medicine, 1992 - 1995
Rush Medical College of Rush University Medical CenterClass of 1992
Certifications & Licensure
MN State Medical License 1994 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Inhaled Sodium Pyruvate for the Treatment of Cystic Fibrosis. Start of enrollment: 2006 Mar 01
- A Phase I Study of Inhaled Sodium Pyruvate for the Treatment of Cystic Fibrosis. Start of enrollment: 2006 Feb 01
- G551D Observational Study- Expanded to Additional Genotypes and Extended for Long Therm Follow up (GOAL-e2) Start of enrollment: 2014 Jan 01
- Join now to see all
Publications & Presentations
PubMed
- Attitudes toward and preparedness for lung transplantation among individuals with cystic fibrosis in the era of highly effective modulators.Nora Burdis, Siddhartha G Kapnadak, Lauren E Bartlett, Oliver McElvaney, Tijana Milinic
BMC Pulmonary Medicine. 2024-07-18 - Seroprevalence of SARS-CoV-2 IgG in people with cystic fibrosis.Kathleen Mahan, Sarah Kiel, Rebecca Freese, Nicholas Marka, Jordan Dunitz
Heliyon. 2024-03-30 - 2 citationsAssessing Safety of Discontinuing Hypertonic Saline in Those with Lower Forced Expiratory Volume in 1 Second after Elexacaftor/Tezacaftor/Ivacaftor.David Nichols, Alex Gifford, Renee Russell, Katherine Odem-Davis, Julia Young
Annals of the American Thoracic Society. 2024-02-01
Journal Articles
- Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19Victor Tapson, Daniel A Sweeney, Richard A Mularski, Alpesh N Amin, Joanne Billings, Marie-Carmelle Elie, The New England Journal of Medicine
Grant Support
- Multidose Safety And Tolerability Study Of Liposomal Amikacin For Inhalation (ArNational Center For Research Resources2009
- Kb001-03: A Phase I/II Randomized, Double-Blind, Placebo-Controlled, Single-DoseNational Center For Research Resources2009
- Expanded Access Program For Aztreonamn Lysine For Inhalation In Patients With CYNational Center For Research Resources2009
- Inhaled Sodium Pyruvate For The Treatment Of Cystic Fibrosis A Phase I, DoubleNational Center For Research Resources2008
- A Phase 3, Double-Blind, Multicenter, Randomized, Placebo-Controlled Trial WithNational Center For Research Resources2008
- Women'S Health In Cystic FibrosisNational Center For Research Resources2004–2007
- A Phase II, Randomized, Double Blind, Parallel Dose Study Of Oral Theraclec-TotaNational Center For Research Resources2005–2006
- Women'S Health In Cystic FibrosisNational Heart, Lung, And Blood Institute2001–2005
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
